Detalles de la búsqueda
1.
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA Trial.
J Clin Rheumatol
; 29(1): 16-22, 2023 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459119
2.
Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast.
J Drugs Dermatol
; 19(4): 378-383, 2020 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272514
3.
Biosimilars: Considerations for Payers.
P T
; 44(2): 54-63, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30766011
4.
Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast.
J Drugs Dermatol
; 17(10): 1078-1082, 2018 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30365588
5.
Impact of osteoporosis on high-cost chronic diseases.
Value Health
; 17(1): 43-50, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24438716
6.
Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study.
ACR Open Rheumatol
; 5(4): 167-172, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36762609
7.
Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis.
ACR Open Rheumatol
; 4(11): 935-941, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971643
8.
Association of physician specialty with psoriatic arthritis treatment and costs.
Am J Manag Care
; 27(7): e226-e233, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34314123
9.
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination.
RMD Open
; 7(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33452180
10.
Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data.
J Manag Care Spec Pharm
; 26(8): 1039-1049, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32715967
11.
The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis.
J Manag Care Spec Pharm
; 26(10): 1236-1242, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996384
12.
Psoriatic arthritis treatment patterns and costs among pharmacologic treatment-naïve patients.
Am J Manag Care
; 26(8): e252-e257, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32835467
13.
Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept.
J Manag Care Spec Pharm
; 26(2): 211-220, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823689
14.
Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study.
Rheumatol Adv Pract
; 3(1): rkz015, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31763619
15.
The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Clin Rheumatol
; 38(11): 3081-3092, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31353421
16.
Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial.
Rheumatol Ther
; 6(2): 245-254, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30915626
17.
Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council.
Am J Clin Dermatol
; 20(5): 699-709, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228013
18.
Cost of biologic treatment persistence or switching in rheumatoid arthritis.
Am J Manag Care
; 24(8 Spec No.): SP338-SP345, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020745
19.
Disease-modifying antirheumatic drug initiation among patients newly diagnosed with rheumatoid arthritis.
Am J Manag Care
; 24(8 Spec No.): SP279-SP285, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020740
20.
Two-year adherence and costs for biologic therapy for rheumatoid arthritis.
Am J Manag Care
; 24(8 Spec No.): SP315-SP321, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020744